Grant

A Randomised, Double-blind, Parallel Group Phase III Study To Assess The Efficacy And Safety Of 100 Mg Sc Depemokimab In Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Anchor 2 Depem

Sponsored by PPD Investigator Services, LLC.

Active

$203.2K Funding

2 People

External

Related Topics

chronic rhinosinusitis, nasal polyps, efficacy, safety

People

Eugene Chang
Principal Investigator (PI)
Otolaryngology﹒Professor
Nirushan Narendran
(CD)
Asthma/Airway Disease Rsch Ctr﹒Clinical Research Coordinator III